Akero Therapeutics, Inc. Operating Lease Right-of-Use Assets
Akero Therapeutics, Inc. had Operating Lease Right-of-Use Assets of $552.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2025-11-07
- 2025-09-30: Operating Lease, Right-of-Use Asset $552.00K.
- 2025-06-30: Operating Lease, Right-of-Use Asset $621.00K.
- 2025-03-31: Operating Lease, Right-of-Use Asset $689.00K.
- 2024-12-31: Operating Lease, Right-of-Use Asset $755.00K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-09-30 | $552.00K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $621.00K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $689.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $755.00K 10-Q · filed 2025-11-07 |
| 2024-09-30 | $820.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $884.00K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $946.00K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $1.01M 10-K · filed 2025-02-28 |
| 2023-09-30 | $1.07M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $1.13M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $1.19M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.24M 10-K · filed 2024-02-29 |
| 2022-09-30 | $1.30M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $1.35M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $1.41M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $1.46M 10-K · filed 2023-03-17 |
| 2021-09-30 | $1.51M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $1.56M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $1.61M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $1.66M 10-K · filed 2022-02-25 |
| 2020-09-30 | $1.71M 10-Q · filed 2020-11-12 |
| 2020-03-31 | $226.00K 10-Q · filed 2020-05-13 |
| 2020-01-01 | $280.00K 10-K · filed 2021-03-16 |